| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 101.13B | 56.25B | 96.36B | 73.02B | 49.60B | 31.90B |
| Gross Profit | 22.16B | 12.71B | 21.11B | 15.41B | 10.37B | 7.66B |
| EBITDA | 18.51B | 8.36B | 17.03B | 10.96B | 6.74B | 4.61B |
| Net Income | 10.25B | 3.82B | 10.20B | 7.98B | 5.81B | 3.29B |
Balance Sheet | ||||||
| Total Assets | 103.87B | 110.29B | 116.78B | 70.60B | 41.92B | 27.24B |
| Cash, Cash Equivalents and Short-Term Investments | 18.89B | 10.43B | 17.33B | 12.14B | 14.12B | 10.08B |
| Total Debt | 47.98B | 52.99B | 53.20B | 22.40B | 3.47B | 2.69B |
| Total Liabilities | 68.92B | 70.44B | 79.77B | 41.68B | 20.52B | 11.31B |
| Stockholders Equity | 34.95B | 39.85B | 37.01B | 28.92B | 21.40B | 15.93B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.30B | -22.31B | -19.01B | 3.66B | 954.82M |
| Operating Cash Flow | 0.00 | 4.68B | -20.20B | -18.66B | 4.68B | 1.13B |
| Investing Cash Flow | 0.00 | -1.47B | -2.74B | 386.99M | 64.81M | 134.01M |
| Financing Cash Flow | 0.00 | -6.91B | 27.18B | 17.45B | -24.90M | -881.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | ¥64.99B | 12.23 | ― | 3.95% | 2.75% | 25.75% | |
77 Outperform | ¥70.64B | 15.14 | ― | 2.79% | 4.22% | 7.91% | |
65 Neutral | ¥226.80B | 17.54 | 8.17% | 2.04% | 4.34% | 98.54% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥74.51B | 13.54 | ― | 3.09% | 7.43% | 47.68% | |
57 Neutral | ¥182.45B | 50.53 | ― | 2.86% | -41.63% | -62.81% | |
50 Neutral | ¥6.77B | 113.28 | ― | 1.65% | 3.81% | ― |